(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 16.1% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 12.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Progyny's revenue in 2024 is $1,108,282,000.On average, 4 Wall Street analysts forecast PGNY's revenue for 2024 to be $119,715,257,781, with the lowest PGNY revenue forecast at $118,016,520,707, and the highest PGNY revenue forecast at $123,320,313,029. On average, 5 Wall Street analysts forecast PGNY's revenue for 2025 to be $140,411,474,318, with the lowest PGNY revenue forecast at $129,928,628,776, and the highest PGNY revenue forecast at $151,267,584,957.
In 2026, PGNY is forecast to generate $166,094,874,389 in revenue, with the lowest revenue forecast at $155,762,001,430 and the highest revenue forecast at $178,110,296,904.